ABSTRACT
Introduction
Different types of diseases, modern methods of diagnosis, and development of the applied technologies have led to increase in the number of clients who refer to the medical centers. This in turn, has led to the increase of hygiene and safety problems 1 . According to WHO statistics, 85
percent of the wastes produced in the health centers are non-hazardous or public wastes mostly produced by official activities or in kitchens. The remaining 15 percent of wastes are known as specific or hazardous wastes (infectious, chemical, and radioactive) that include the irreversible dangers 2 . On the other hand, per capitas of hospital waste production in the US and Iran were estimated as 4.8 kg and 4.3 kg for every bed, respectively 3 . According to the waste management laws, medical wastes include all types of infectious and harmful wastes produced in hospitals, medical centers, and specific management because they include infectious and chemical elements as well as different viruses such as HIV, hepatitis, etc. Inappropriate management of these waste materials has led to irrecoverable damages such as 23 million cases of HIV as well as hepatitis B and C in the individuals who collect the medical wastes 5 . The treatment process is one of the important steps to prevent from such problems. According to the hospital waste management regulations (Iran's Ministry of Health), treatment consists of the logarithmic reduction of microbial agents 6 . The methods of medical waste treatment are incineration, sterilization with chemicals, dry and wet heating, microwaves, and rays 7 . As recommended by WHO, medical wastes should be treated far from the medical site using nonincineration methods [8] [9] . In order to fulfill this process, the waste materials should be separated, sterilized, and secured by the waste producers 10 .
Compared to incineration, dry or wet sterilization requires fewer individuals as well as less operation and maintenance costs. Considering the economic and environmental aspects of incineration, non-incineration methods such as autoclave, chemiclave, and hydroclave are the alternative methods 11 . These methods are not very costly for the consumers; therefore, estimation of the costs of the devices required for each of these methods and evaluating their benefits can help the decision makers to select the best devices 12 . The objective of this study was to evaluate the devices economically in treatment of infectious wastes of hospitals in cities of Isfahan and Yazd.
Materials and Methods
We conducted this economic evaluation study using cost-effectiveness analysis. We calculated the total expenditure related to the hospitals' treatment systems of infectious wastes and conducted ICER as well as sensitivity analysis in reducing the volume and weight of infectious waste using the Treeage 2011 software.
Considering the 5 percent discount rate and 10 years of service life, the cost-effectiveness and ICER were calculated by formula 1.
(1)
In this formula, C and E are the expenditures and consequences, respectively. We initially calculated the additive cost-effectiveness for the nine devices under investigation (autoclave and hydroclave). Due to the intrinsic data uncertainty and in order to increase the precision and accuracy of the calculations, we applied the two-way sensitivity analysis and drew the decision tree. The process of sensitivity analysis determined the sensitivity and generalizability of the results against the fluctuations.
Costs and outputs
Costs, as the inclusion criteria, consisted of the direct costs including the current and investment costs. The investment costs included the construction costs (for the infectious wastes' site and the device operator's office), the investment costs (for buying the land and the required infrastructures to maintain the hazardous devices), the costs of devices and tools for collecting or keeping the wastes (waste collection barrow and waste keeping tools), and the cost of final disposal of the treated waste. The current costs included the costs of consultation, selection and installation of the devices, financial costs (accounting and tax), direct executive costs (special yellow sacks for collecting infectious wastes, sharp and keen objects, energy consumption, fuel, and chemicals), and indirect executive costs (training, repairing, and maintaining the devices and equipment related to the safety of the devices). Finally, the decrease percentage of the wastes' weight and volume were calculated. To evaluate the efficiency and performance of the dvices using the formula 2.
Yearly Working days and Nb produced infectious waste per bed.
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Results
costs and efficiency of the treatment devices are mentioned in the Tables 1 and 2 . Considering the 10-year service life, devices A and F had the highest and the lowest total costs, respectively. Table 2 shows the output efficiency of the treatment devices per month, where the devices F and A with the nominal capacity of 1000 liters turn 24000 and 4200 kg of infectious wastes to normal wastes per month. Issue (4), December 2018, 645-9 Jehsd.ssu.ac.ir 648 
Discussion
Considering the costs of the treatment devices tabulated in Table 1 and by taking into account the service life of 10 years as well as with the discount rate of 5 percent, devices A and F had the highest and the lowest total costs, respectively. In fact, the total cost of the device A with the discount rate of 5 percent was equal to 58468240 Rials; whereas, device F with the cost of 28289703 Rials had the lowest cost. The device E with 4166666 Rials had the lowest investment cost compared to other devices. In addition, regarding the waste collection and maintenance costs, device D had the lowest cost (1500000 Rials) compared to other devices. However, considering the disposal cost of the treated waste, devices A and G with 3250000 Rials had the lowest costs. The highest cost for disposing the treated waste belonged to device B (6750000 Rials). In comparison between autoclave and hydroclave, device I had the total cost of 37190149 Rials, which was less than the autoclave A cost; i.e., 21278091 Rials. This can be due to the fact that waste treatment was conducted in the temperature 121 °C and under the pressure of 1.1 bars. In other words, lower temperatures require less energy; whereas, the waste treatment in the autoclave devices was performed in 138 °C and 2.2 bars pressure [13] [14] . Considering Table 1 , the highest and the lowest costs (repair, maintenance, and operation) belonged to device G (14000000 Rials) and device B (2200000 Rials), respectively. In addition, the devices C (696780 Rials) and E (32820 Rials) had the highest and the lowest costs of monthly energy consumption (water, electricity, and gas). Considering the necessity of infectious waste treatment, device F treated the highest weight (24000 kg) of infectious waste. Table 2 shows that device F with the nominal capacity of 1000 liters turned 24000 kg of infectious waste into non-infectious waste per month; whereas, the treatment quantity of device A with the same capacity (1000 liters) was 4200 kg per month. Considering the per capita of infectious waste production in Iran (1-2 kg) 15 and by taking into account the annual 365 working days in Iran, production of 133 -268 tons of wastes related to personal care can be expected. Therefore, device F had a higher practical capacity in the treatment of infectious waste. Considering ICER, we can observe from Table 3 that autoclave D is more cost-effective than other devices, because it has the lowest amount of ICER, i.e., 257.20. Therefore, device D with treatment of 7500 kg infectious waste per month will be a cost-effective device in a hospital with 163 beds. Considering the sensitivity analysis conducted on the parameters with the highest effects on the cost-effectiveness, we applied the two-way sensitivity analysis [16] [17] . Table  3 shows that device D with the efficiency range of 244.34-270.06 is the best option for infectious waste treatment. The second optimal device for waste treatment is device I with the range of 440.97-487.38. The reason for this could be the advantage of using hydroclave technology, in which the treatment is performed by heating the waste and injecting the steam indirectly 18 . In addition, device A with the range of 1447.95-1600.36 is considered as the last option.
Conclusion
Eventually, we can conclude that more expensive devices are not necessarily the more efficient ones. So, in order to select the best technology, various criteria such as price, effectiveness, service life, the methods of infectious waste treatment in a certain time period, number of beds, and the weight of the produced wastes should be taken into account.
